Société Générale


SG's earnings recovery gains legs as the execution of the strategic plan unfolds

15/04/24 -"We now factor a stronger recovery into our 2024 (+16%) and 2025 (+15%) EPS projections as we see a higher prospect of recovery for SG. Our 2024 upgrade comes on the back of higher revenue (+2%), ..."

Pages
74
Language
English
Published on
15/04/24
You may also be interested by these reports :
27/11/25
Everyone knows the saying, “Buy on the sound of cannons, sell on the sound of the bugle.” Unfortunately, the US considers that Ukraine has lost the ...

25/11/25
Julius Baer’s interim statement to October describes a healthy progression when it comes to asset gathering (+8% to CHF520bn), balance sheet strength ...

20/11/25
Interestingly, European Banks did not escape the last 5 trading days (to 18-11 close) market correction, as doubts surfaced about AI’s lack of a ...

17/11/25
As its name suggests, Swiss Life (REDUCE ; Switzerland) focuses on pensions and savings – it is in fact one of the few pure (or almost pure) plays in ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO